Literature DB >> 24056371

The chemokine receptor CCR1 is constitutively active, which leads to G protein-independent, β-arrestin-mediated internalization.

C Taylor Gilliland1, Catherina L Salanga, Tetsuya Kawamura, JoAnn Trejo, Tracy M Handel.   

Abstract

Activation of G protein-coupled receptors by their associated ligands has been extensively studied, and increasing structural information about the molecular mechanisms underlying ligand-dependent receptor activation is beginning to emerge with the recent expansion in GPCR crystal structures. However, some GPCRs are also able to adopt active conformations in the absence of agonist binding that result in the initiation of signal transduction and receptor down-modulation. In this report, we show that the CC-type chemokine receptor 1 (CCR1) exhibits significant constitutive activity leading to a variety of cellular responses. CCR1 expression is sufficient to induce inhibition of cAMP formation, increased F-actin content, and basal migration of human and murine leukocytes. The constitutive activity leads to basal phosphorylation of the receptor, recruitment of β-arrestin-2, and subsequent receptor internalization. CCR1 concurrently engages Gαi and β-arrestin-2 in a multiprotein complex, which may be accommodated by homo-oligomerization or receptor clustering. The data suggest the presence of two functional states for CCR1; whereas receptor coupled to Gαi functions as a canonical GPCR, albeit with high constitutive activity, the CCR1·β-arrestin-2 complex is required for G protein-independent constitutive receptor internalization. The pertussis toxin-insensitive uptake of chemokine by the receptor suggests that the CCR1·β-arrestin-2 complex may be related to a potential scavenging function of the receptor, which may be important for maintenance of chemokine gradients and receptor responsiveness in complex fields of chemokines during inflammation.

Entities:  

Keywords:  Arrestin; Bioluminescence Resonance Energy Transfer (BRET); CCR1; Cell Migration; Chemokines; Constitutive Activity; G Protein-coupled Receptors (GPCR); Internalization

Mesh:

Substances:

Year:  2013        PMID: 24056371      PMCID: PMC3820859          DOI: 10.1074/jbc.M113.503797

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  94 in total

Review 1.  Chemokine receptor oligomerization: a further step toward chemokine function.

Authors:  Laura Martínez Muñoz; Borja López Holgado; Carlos Martínez-A; José Miguel Rodríguez-Frade; Mario Mellado
Journal:  Immunol Lett       Date:  2012-07-30       Impact factor: 3.685

2.  Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues.

Authors:  Astrid E Cardona; Margaret E Sasse; Liping Liu; Sandra M Cardona; Makiko Mizutani; Carine Savarin; Taofang Hu; Richard M Ransohoff
Journal:  Blood       Date:  2008-03-17       Impact factor: 22.113

3.  Distinct conformational changes in beta-arrestin report biased agonism at seven-transmembrane receptors.

Authors:  Arun K Shukla; Jonathan D Violin; Erin J Whalen; Diane Gesty-Palmer; Sudha K Shenoy; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-11       Impact factor: 11.205

4.  Functional reconstitution of the human chemokine receptor CXCR4 with G(i)/G (o)-proteins in Sf9 insect cells.

Authors:  Patrick Kleemann; Dan Papa; Sandy Vigil-Cruz; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-06-04       Impact factor: 3.000

5.  How and why do GPCRs dimerize?

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Trends Pharmacol Sci       Date:  2008-04-01       Impact factor: 14.819

6.  Monitoring protein-protein interactions in living cells by bioluminescence resonance energy transfer (BRET).

Authors:  Fadi F Hamdan; Yann Percherancier; Billy Breton; Michel Bouvier
Journal:  Curr Protoc Neurosci       Date:  2006-02

Review 7.  Review: Structure-function and biological properties of the atypical chemokine receptor D6.

Authors:  Cinzia Cancellieri; Nicoletta Caronni; Alessandro Vacchini; Benedetta Savino; Elena M Borroni; Massimo Locati; Raffaella Bonecchi
Journal:  Mol Immunol       Date:  2012-08-29       Impact factor: 4.407

8.  Dissecting trafficking and signaling of atypical chemokine receptors.

Authors:  Elena Borroni; Cinzia Cancellieri; Massimo Locati; Raffaella Bonecchi
Journal:  Methods Enzymol       Date:  2013       Impact factor: 1.600

Review 9.  Chemokine receptor oligomerization and allostery.

Authors:  Bryan Stephens; Tracy M Handel
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

10.  Development of operational models of receptor activation including constitutive receptor activity and their use to determine the efficacy of the chemokine CCL17 at the CC chemokine receptor CCR4.

Authors:  R J Slack; D A Hall
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

View more
  28 in total

Review 1.  When trafficking and signaling mix: How subcellular location shapes G protein-coupled receptor activation of heterotrimeric G proteins.

Authors:  Braden T Lobingier; Mark von Zastrow
Journal:  Traffic       Date:  2019-02       Impact factor: 6.215

Review 2.  Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors.

Authors:  Chang Liu; Guohong Cui; Meiping Zhu; Xiangping Kang; Haidong Guo
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

3.  A naturally occurring GIP receptor variant undergoes enhanced agonist-induced desensitization, which impairs GIP control of adipose insulin sensitivity.

Authors:  Sameer Mohammad; Rajesh T Patel; Joanne Bruno; Muhammad Siyab Panhwar; Jennifer Wen; Timothy E McGraw
Journal:  Mol Cell Biol       Date:  2014-07-21       Impact factor: 4.272

4.  Identifying bias in CCR1 antagonists using radiolabelled binding, receptor internalization, β-arrestin translocation and chemotaxis assays.

Authors:  A Gilchrist; T D Gauntner; A Fazzini; K M Alley; D S Pyen; J Ahn; S J Ha; A Willett; S E Sansom; J L Yarfi; K A Bachovchin; M R Mazzoni; J R Merritt
Journal:  Br J Pharmacol       Date:  2014-11       Impact factor: 8.739

5.  CCR2-Mediated Uptake of Constitutively Produced CCL2: A Mechanism for Regulating Chemokine Levels in the Blood.

Authors:  Bin N Zhao; James J Campbell; Catherina L Salanga; Linda S Ertl; Yu Wang; Simon Yau; Ton Dang; Yibin Zeng; Jeffrey P McMahon; Antoni Krasinski; Penglie Zhang; Irina Kufareva; Tracy M Handel; Israel F Charo; Rajinder Singh; Thomas J Schall
Journal:  J Immunol       Date:  2019-11-01       Impact factor: 5.422

6.  Encoding the β-Arrestin Trafficking Fate of Ghrelin Receptor GHSR1a: C-Tail-Independent Molecular Determinants in GPCRs.

Authors:  Krisztian Toth; Karim Nagi; Lauren M Slosky; Lauren Rochelle; Caroline Ray; Suneet Kaur; Sudha K Shenoy; Marc G Caron; Larry S Barak
Journal:  ACS Pharmacol Transl Sci       Date:  2019-06-03

7.  Structural biology. Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor.

Authors:  John S Burg; Jessica R Ingram; A J Venkatakrishnan; Kevin M Jude; Abhiram Dukkipati; Evan N Feinberg; Alessandro Angelini; Deepa Waghray; Ron O Dror; Hidde L Ploegh; K Christopher Garcia
Journal:  Science       Date:  2015-03-06       Impact factor: 47.728

8.  GPCR-G Protein-β-Arrestin Super-Complex Mediates Sustained G Protein Signaling.

Authors:  Alex R B Thomsen; Bianca Plouffe; Thomas J Cahill; Arun K Shukla; Jeffrey T Tarrasch; Annie M Dosey; Alem W Kahsai; Ryan T Strachan; Biswaranjan Pani; Jacob P Mahoney; Liyin Huang; Billy Breton; Franziska M Heydenreich; Roger K Sunahara; Georgios Skiniotis; Michel Bouvier; Robert J Lefkowitz
Journal:  Cell       Date:  2016-08-04       Impact factor: 41.582

9.  CSBF/C10orf99, a novel potential cytokine, inhibits colon cancer cell growth through inducing G1 arrest.

Authors:  Wen Pan; Yingying Cheng; Heyu Zhang; Baocai Liu; Xiaoning Mo; Ting Li; Lin Li; Xiaojing Cheng; Lianhai Zhang; Jiafu Ji; Pingzhang Wang; Wenling Han
Journal:  Sci Rep       Date:  2014-10-29       Impact factor: 4.379

10.  Analysis of Chemokine Receptor Trafficking by Site-Specific Biotinylation.

Authors:  Marcel Liebick; Christian Schläger; Martin Oppermann
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.